Tag: research

Researchers have discovered a new drug could potentially halt the spread of glioblastoma cells

Scientists identify a subgroup of children diagnosed with medulloblastoma that could be given less aggressive treatments

Our Research Communications Assistant, Arshiya, gives an overview of the International Symposium on Paediatric Neuro-Oncology (ISPNO)

Results of two phase 2 clinical trials testing cabozantinib suggest that anti-angiogenic therapy could be used to treat glioblastomas

Our Research Engagement Manager Becky Birch, outlines developments highlighted by Tessa Jowell’s debate

Our Head of Research, Phil Hexley, outlines what happened at SNO: the 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology

Our Head of Research, Phil Hexley, outlines what happened at SNO: the 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology

PAC-1, an anti-cancer drug is approved for phase 1(b) clinical trials in humans by the US Food and Drug Administration

A gene therapy to treat recurrent high-grade gliomas is accelerated to Phase 3 clinical trials, after the success of Phase 1 clinical trials by the US Food and Drug Administration (FDA)

A research team at the University of Texas, led by Professor George Biros have been able to accurately characterise gliomas using a super computer

Professor Frank Winkler and his team at Heidelberg University in Germany have discovered a potential mechanism that could explain glioma recurrence

Researchers at Stanford University discover that the absence of a particular protein halts the growth of high-grade gliomas

Researchers have barcoded cancer cells to learn more about growth patterns in hopes of developing more targeted treatments.

Researchers have developed ‘nanoswimmers’ that cross the blood brain barrier highly efficiently.

In a new article for Nature Communication, scientists Gelareh Zadeh and Ken Aldape explain that radiation given during childhood cancer treatments causes DNA to rearrange. This rearrangement of DNA can then lead to menigiomas.

The group of researchers at UCL, funded by The Charity are led by Professor Paolo Salomoni and have discovered that cells are capable of migrating through tissues in the body

This promising technique was developed by Researchers from the University of Oxford, UK and the University of Twente, Netherlands

The annual report by Prof Dame Sally Davies says that the genomic plan should be implemented within 5 years in the NHS

A probe that was first developed by researchers in Canada in 2015 has since been perfected by the team

A new study from the CSIR-Institute of Genomics and Integrative Biology in India examined the mechanism of gene expression within brain tumours and found a lack of microRNA editing

A study conducted by Judith Schwartzbaum from the University of Ohio has found that changes in the immune systems appear to signal brain cancer 5 years before symptoms arise

Researchers from the University of Texas MD Anderson have discovered an enzyme that helps brain tumours grow in nutrient-starved environments

The terminal illness charity is looking for applications that address its key research priorities identified by carers, health and social care professionals and people with terminal illness, and particularly, those areas that have until now received the least attention

Researchers at McGill University Health Centre (MUHC), Montreal have developed a new clinical approach to enhance the efficiency of treatment for glioblastomas, which increased the average survival time to 22 months.